I didn't say the vaccines have no value. I said that until we get a lot more data than we have no one is going to care. Peptide vaccines aren't new and amazing. They aren't ground breaking. That doesn't mean they don't have value. They do. The $70M we got was all because of the cell therapy. It had nothing to do with the vaccines. If there was interest from the large VCs in the vaccines then they would have already invested. This is all what I was told directly by the company.
My opinion on valuation remains the same. Somewhere around $1B. None of my thoughts have changed other than a bit of disappointment that data was released two months ago and the company didn't even mention it.
News 
Market Data 
Discover 
